Teleflex Incorporated (NYSE:TFX) Shares Acquired by NewEdge Wealth LLC

NewEdge Wealth LLC increased its holdings in Teleflex Incorporated (NYSE:TFX) by 7.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,278 shares of the medical technology company’s stock after acquiring an additional 282 shares during the quarter. NewEdge Wealth LLC’s holdings in Teleflex were worth $1,067,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of TFX. Cambridge Investment Research Advisors Inc. increased its holdings in shares of Teleflex by 2.5% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 2,231 shares of the medical technology company’s stock valued at $792,000 after acquiring an additional 54 shares during the period. HighTower Advisors LLC increased its holdings in shares of Teleflex by 2.2% in the 1st quarter. HighTower Advisors LLC now owns 4,678 shares of the medical technology company’s stock valued at $1,655,000 after acquiring an additional 99 shares during the period. Private Advisor Group LLC acquired a new position in shares of Teleflex in the 1st quarter valued at $455,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in shares of Teleflex by 6.6% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,268 shares of the medical technology company’s stock valued at $2,224,000 after acquiring an additional 388 shares during the period. Finally, Yousif Capital Management LLC increased its holdings in shares of Teleflex by 2.7% in the 1st quarter. Yousif Capital Management LLC now owns 7,158 shares of the medical technology company’s stock valued at $2,540,000 after acquiring an additional 190 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Royal Bank of Canada lowered their price objective on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a research report on Friday, February 23rd. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 23rd. JMP Securities reiterated a “market outperform” rating and issued a $285.00 price objective on shares of Teleflex in a research report on Friday, February 23rd. Truist Financial lowered their price objective on shares of Teleflex from $270.00 to $265.00 and set a “hold” rating on the stock in a research report on Friday, February 23rd. Finally, Raymond James lifted their price objective on shares of Teleflex from $227.00 to $271.00 and gave the company an “outperform” rating in a research report on Wednesday, December 20th. Five equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, Teleflex presently has a consensus rating of “Moderate Buy” and a consensus price target of $265.56.

Teleflex Price Performance

Teleflex stock opened at $210.66 on Tuesday. Teleflex Incorporated has a 52 week low of $177.63 and a 52 week high of $276.43. The company has a quick ratio of 1.29, a current ratio of 2.32 and a debt-to-equity ratio of 0.39. The firm’s 50-day simple moving average is $228.97 and its 200 day simple moving average is $225.23. The firm has a market capitalization of $9.92 billion, a PE ratio of 27.98, a P/E/G ratio of 2.05 and a beta of 1.11.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $3.38 EPS for the quarter, topping the consensus estimate of $3.26 by $0.12. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. The business had revenue of $773.90 million for the quarter, compared to analyst estimates of $769.01 million. During the same period in the previous year, the firm earned $3.52 EPS. The business’s revenue for the quarter was up 2.1% compared to the same quarter last year. On average, equities research analysts predict that Teleflex Incorporated will post 13.73 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Friday, March 1st were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date of this dividend was Thursday, February 29th. Teleflex’s dividend payout ratio is currently 18.06%.

Insider Transactions at Teleflex

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total value of $1,665,225.00. Following the sale, the vice president now directly owns 10,050 shares of the company’s stock, valued at $2,261,250. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.43% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.